Literature DB >> 30778918

A cardiac magnetic resonance imaging study of long-term and incident hemodialysis patients.

Richard B Thompson1, Paolo Raggi2, Natasha Wiebe3, Martin Ugander4, Jannike Nickander4, Scott W Klarenbach3, Stephanie Thompson3, Marcello Tonelli5.   

Abstract

BACKGROUND: The cardiovascular morphology and function in long-term survivors of hemodialysis are not well described.
METHODS: Single-center cross-sectional study nested within a prospective cohort study of 15 long-term (> 7.5 years) and 15 matched incident (< 6 months) hemodialysis patients with 15 external matched controls. Evaluations included heart structure, function and fibrosis (myocardial longitudinal relaxation time, native T1), and aortic dimensions and elasticity, using cardiovascular magnetic resonance (CMR). Coronary artery calcification (CAC) scores were evaluated from computed tomography (CT).
RESULTS: Incident hemodialysis patients had significantly increased left ventricular mass, greater aortic dimensions and reduced aortic distensibility compared to long-term survivors, whereas the CAC score was significantly higher in long-term than incident patients, median (95% CI) 1127 (10-3861) vs 14 (0-268). Both incident and long-term hemodialysis groups had significantly higher native T1 values compared to controls, mean (95% CI) 1300 ms (1273-1326), 1274 ms (1243-1305) versus 1224 ms (1202-1246), respectively, suggesting interstitial fibrosis or edema. Compared to controls, both hemodialysis groups also had significantly lower left ventricular ejection fraction: 48.7% (43.6-53.9), 54.0% (48.3-59.7) versus 62.2% (58.0-66.4) and longitudinal strain: 14.0% (11.7-16.2), 15.2% (12.7-17.7) versus 19.6% (17.8-21.5).
CONCLUSIONS: Incident hemodialysis patients had larger left ventricular mass and unfavorable aortic structure and function compared to long-term survivors, despite a lower CAC burden. Long-term survivors, despite normal ventricular mass and volumes, had signs of fibrosis or edema, given their significantly increased native T1 values.

Entities:  

Keywords:  Aortic compliance; Aortic diameter; Hemodialysis; Myocardial fibrosis; Myocardial hypertrophy

Year:  2019        PMID: 30778918     DOI: 10.1007/s40620-019-00593-3

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  36 in total

1.  Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis.

Authors:  Y Matsumoto; M Hamada; K Hiwada
Journal:  Angiology       Date:  2000-11       Impact factor: 3.619

Review 2.  The clinical significance of aortic compliance and its assessment with magnetic resonance imaging.

Authors:  Zafiria M Metafratzi; Stavros C Efremidis; Antigoni S Skopelitou; Albert De Roos
Journal:  J Cardiovasc Magn Reson       Date:  2002       Impact factor: 5.364

3.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

4.  Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients.

Authors:  Jiro Aoki; Yuji Ikari; Hiroyoshi Nakajima; Masaya Mori; Tokuichiro Sugimoto; Mitsuharu Hatori; Shuzou Tanimoto; Eisuke Amiya; Kazuhiro Hara
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

5.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

Review 6.  Left ventricular mass in chronic kidney disease and ESRD.

Authors:  Richard J Glassock; Roberto Pecoits-Filho; Silvio H Barberato
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

7.  Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.

Authors:  Ming-Cheng Wang; Wei-Chuan Tsai; Ju-Yi Chen; Jeng-Jong Huang
Journal:  Am J Kidney Dis       Date:  2005-03       Impact factor: 8.860

8.  Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart.

Authors:  Daniel R Messroghli; Aleksandra Radjenovic; Sebastian Kozerke; David M Higgins; Mohan U Sivananthan; John P Ridgway
Journal:  Magn Reson Med       Date:  2004-07       Impact factor: 4.668

9.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

10.  Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Authors:  Patrick B Mark; Arthur Doyle; Kevin G Blyth; Rajan K Patel; Robin A P Weir; Tracey Steedman; John E Foster; Henry J Dargie; Alan G Jardine
Journal:  J Cardiovasc Magn Reson       Date:  2008-08-18       Impact factor: 5.364

View more
  1 in total

1.  Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.

Authors:  Le Qin; Shengjia Gu; Ruijie Xiao; Peng Liu; Fuhua Yan; Haijin Yu; Wenjie Yang
Journal:  Eur Radiol       Date:  2022-05-12       Impact factor: 7.034

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.